Home | Medical Dictionary | Contact Us         
 
 
  • About
    Cedars-Sinai
  • Careers at
    Cedars-Sinai
  • Giving
    & Support
  • Health
    Conditions
  • Healthcare
    Professionals
  • Patients
    & Visitors
  • Programs
    & Services
  • Quality
    Measures
  • Research &
    Education
  • Programs and Services
  • Samuel Oschin Comprehensive Cancer Institute
  • Advances in Cancer
  • Cancers Treated
  • Centers and Programs
  • Contact Us
  • Events
  • For Patients
  • For Physicians
  • Genetic Screening
  • In the News
  • Inpatient Services
  • Our Expert Team
  • Outpatient Cancer Center
  • Quality Measures & Outcomes
  • Research
  • Blood Cell Development Research
  • Brain Tumor Research
  • Breast Cancer Research
  • Clinical Trials
  • Gene Cloning Research
  • Kaposi's Sarcoma Virus Research
  • Leukemia & Lymphoma Research
  • Non-Hodgkin's Lymphoma Research
  • Ovarian Cancer Research
  • Prostate Cancer Research
  • Stem Cell Biology Research
  • Tumor Suppressor Gene Research
  • Women's Cancer Research Institute
  • Shared Resources
 

Non-Hodgkin's Lymphoma Research

Many tumors take on added and more complex chromosome abnormalities as they progress.

In chronic myelogenous leukemia (CML), this is a factor of certain secondary cell changes and the course of the disease in later stages.

Research is ongoing to see if there is a correlation with specific types of lymphoma. Data are also being compared to results of genetics research.

Back to Top

 
Cedars-Sinai Logo

© Copyright 2000-2009 Cedars-Sinai Health System.
All rights reserved.
Privacy Policy Terms and Conditions